Management of lymphoma recurrence after allogeneic transplantation: The relevance of graft-versus-lymphoma effect

被引:173
作者
vanBesien, KW
deLima, M
Giralt, SA
Moore, DF
Khouri, IF
Rondon, G
Mehra, R
Andersson, BS
Dyer, C
Cleary, K
Przepiorka, D
Gajewski, JL
Champlin, RE
机构
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT GASTROINTESTINAL ONCOL & DIGEST DIS,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PATHOL,HOUSTON,TX 77030
[3] CAN CTR KANSAS PA,WICHITA,KS
关键词
lymphoma; allogeneic transplantation; graft-versus-lymphoma; recurrence;
D O I
10.1038/sj.bmt.1700781
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Donor lymphocyte infusions, by virtue of a graft-versus-tumor effect, have been shown to induce remissions in leukemia that recurs after allogeneic bone marrow transplantation. Similar effects have been postulated to contribute to the decreased recurrence rate observed after allogeneic transplantation in non-Hodgkin's lymphoma. This lower recurrence rate may be due to a variety of other mechanisms. We aimed to evaluate the role of graft-versus-lymphoma effects in patients in whom lymphomas recur after allogeneic transplantation. At the time of recurrence, immunosuppressive therapy was withheld. Patients with non-responding disease received an infusion of donor lymphocytes, Patients were observed for response and graft-versus-host disease. Disease in four of nine patients responded to withdrawal of immunosuppressive therapy, A minor response was observed in one of three recipients of donor lymphocyte infusions, Responses were observed among two patients with follicular lymphoma, one with large cell lymphoma and one with lymphoblastic lymphoma, A minor response was observed in a patient with prolymphocytic leukemia/lymphoma. We conclude that withdrawal of immunosuppressive therapy and donor lymphocyte infusion can induce durable remissions in patients with recurrent lymphoma after allogeneic transplantation.
引用
收藏
页码:977 / 982
页数:6
相关论文
共 29 条
[1]  
APPELBAUM FR, 1993, MARROW TRANSPLANT RE, V3, P1
[2]   Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma [J].
deLima, M ;
vanBesien, KW ;
Giralt, SA ;
Khouri, IF ;
Mehra, R ;
Andersson, BS ;
Przepiorka, D ;
Gajewski, JL ;
Korbling, M ;
Champlin, RE .
BONE MARROW TRANSPLANTATION, 1997, 19 (02) :121-127
[3]  
FEFER A, 1994, BONE MARROW TRANSPL, P231
[4]  
FIELDING AK, 1995, BONE MARROW TRANSPL, V15, pS96
[5]   AIDS-RELATED LYMPHOMAS - FROM PATHOGENESIS TO PATHOLOGY [J].
GAIDANO, G ;
CARBONE, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) :235-243
[6]   ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES [J].
GIRALT, SA ;
LEMAISTRE, CF ;
VRIESENDORP, HM ;
ANDERSSON, BS ;
DIMOPOULOS, M ;
GAJEWSKI, J ;
VANBESIEN, K ;
MEHRA, R ;
PRZEPIORKA, D ;
KHOURI, I ;
YAU, J ;
KANTARJIAN, H ;
DEISSEROTH, AB ;
CHAMPLIN, RE .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) :1923-1930
[7]  
JONES RJ, 1991, BLOOD, V77, P649
[8]   GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].
KOLB, HJ ;
SCHATTENBERG, A ;
GOLDMAN, JM ;
HERTENSTEIN, B ;
JACOBSEN, N ;
ARCESE, W ;
LJUNGMAN, P ;
FERRANT, A ;
VERDONCK, L ;
NIEDERWIESER, D ;
VANRHEE, F ;
MITTERMUELLER, J ;
DEWITTE, T ;
HOLLER, E ;
ANSARI, H .
BLOOD, 1995, 86 (05) :2041-2050
[9]  
KOLB HJ, 1993, BLOOD, V82, pA214
[10]   ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR REFRACTORY LEUKEMIA AND LYMPHOMA - POTENTIAL ADVANTAGE OF BLOOD OVER MARROW ALLOGRAFTS [J].
KORBLING, M ;
PRZEPIORKA, D ;
HUH, YO ;
ENGEL, H ;
VANBESIEN, K ;
GIRALT, S ;
ANDERSSON, B ;
KLEINE, HD ;
SEONG, D ;
DEISSEROTH, AB ;
ANDREEFF, M ;
CHAMPLIN, R .
BLOOD, 1995, 85 (06) :1659-1665